Elevated Basic Fibroblast Growth Factor Levels in Patients With Pulmonary Arterial Hypertension
Authors:
- Jacques I. BenistyJBJacques I. Benisty
- Vallerie V. McLaughlinVMVallerie V. McLaughlin
- Michael J. LandzbergMLMichael J. Landzberg
- Jonathan D. RichJRJonathan D. Rich
- Jane W. NewburgerJNJane W. Newburger
- Stuart RichSRStuart Rich
- Judah FolkmanJFJudah Folkman
- 1 October 2004
- Vol. 126 (4) , 1255-1261
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- CLINICAL CLASSIFICATION OF PULMONARY HYPERTERNSIONClinics in Chest Medicine, 2001
- Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesisThe Journal of Pathology, 2001
- Histopathology of Pulmonary HypertensionChest, 1998
- Vascular endothelial growth factor and its receptorsCytokine & Growth Factor Reviews, 1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Elastase and cell matrix interactions in the pathobiology of vascular diseasePediatrics International, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Basic Fibroblast Growth Factor Alterations During Development of Monocrotaline-Induced Pulmonary Hypertension in RatsGrowth Factors, 1995
- Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.Circulation, 1989
- Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix.Proceedings of the National Academy of Sciences, 1987